Global Montelukast Sodium Tablet Market Growth 2024-2030
The main ingredient of montelukast sodium tablets is montelukast sodium, an oral leukotriene receptor antagonist
The global Montelukast Sodium Tablet market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Montelukast Sodium Tablet Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Tablet sales in 2023, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Tablet sales for 2024 through 2030. With Montelukast Sodium Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Tablet industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Tablet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Tablet.
United States market for Montelukast Sodium Tablet is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Montelukast Sodium Tablet is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Montelukast Sodium Tablet is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Montelukast Sodium Tablet players cover Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Jiangsu Vanguard Pharmaceutical Co.,Ltd., Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Organon Pharma (UK) Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Tablet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Original Drug
Generic Drug
Segmentation by Application:
Hospital
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
Jiangsu Vanguard Pharmaceutical Co.,Ltd.
Lunan Better Pharmaceutical Co.,Ltd
Otsuka
Organon Pharma (UK) Limited
Taiwan Biotech Co., Ltd
Sandoz Private Limited
N.V. Organon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium Tablet market?
What factors are driving Montelukast Sodium Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium Tablet market opportunities vary by end market size?
How does Montelukast Sodium Tablet break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.